Back to search

Article

Iron Chelation Improves Ineffective Erythropoiesis and Iron Overload in Myelodysplastic Syndrome Mice

2022-10-07

Abstract excerpt

<h4>ABSTRACT</h4> Myelodysplastic syndrome (MDS) is a heterogeneous group of bone marrow stem cell disorders characterized by ineffective hematopoiesis and cytopenias, most commonly anemia. Red cell transfusion therapy for anemia in MDS results in iron overload, correlating with reduced overall survival. Whether treatment of iron overload benefits MDS patients remains controversial. We evaluate underlying iron-re...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a57d565f-77f6-5915-b6ed-7a792e490145
DOI
10.1101/2022.10.05.510967
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Iron Chelation Improves Ineffective Erythropoiesis and Iron Overload in Myelodysplastic Syndrome MiceDOI 10.1101/2022.10.05.510967
Select a neighboring publication to make it the new centre.